ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, we investigated whether KW-2478 could increase the sensitivity of CML cells to imatinib and whether KW-2478 could overcome the imatinib resistance caused by BCR/ABL amplification.